Clinical Research Detail Title Of Study Evaluation of the Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride Levels >/= 500 mg/dL. Disease Condition Hypertriglyceridemia Phase of Trial Phase-3 Discipline Pharmacology Start date of Trial 12/14/2009 Closing Date of Trial 3/14/2011 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]